P09.2
Billable codeAbnormal findings on neonatal screening for congenital endocrine disease
The ICD-10 code for abnormal findings on neonatal screening for congenital endocrine disease is P09.2.
Clinical notes
Also known as
Alternate wording, synonyms, or specific conditions that fall under this code, listed to help confirm you've picked the right one.
- Abnormal findings on neonatal screening for congenital adrenal hyperplasia
- Abnormal findings on neonatal screening for hypothyroidism screen
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- P09.1Abnormal findings on neonatal screening for inborn errors of metabolism
- P09.3Abnormal findings on neonatal screening for congenital hematologic disorders
- P09.4Abnormal findings on neonatal screening for cystic fibrosis
- P09.5Abnormal findings on neonatal screening for critical congenital heart disease
- P09.6Abnormal findings on neonatal hearing screening
- P09.8Other abnormal findings on neonatal screening
- P09.9Abnormal findings on neonatal screening, unspecified
- P09.2Abnormal findings on neonatal screening for congenital endocrine disease
Associated MS-DRGs
P09.2 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.